In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $96.91 in the prior trading day, Healthequity Inc (NASDAQ: HQY) closed at $94.38, down -2.61%. In other words, the price has decreased by -$2.61 from its previous closing price. On the day, 0.67 million shares were traded. HQY stock price reached its highest trading level at $97.54 during the session, while it also had its lowest trading level at $94.37.
Ratios:
Our goal is to gain a better understanding of HQY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.17. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On March 25, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also lowered its target price recommendation from $120 to $115.
On December 04, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $126.Mizuho initiated its Outperform rating on December 04, 2024, with a $126 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 03 ’25 when Delano Ladd bought 970 shares for $100.87 per share.
James M. Lucania bought 2,375 shares of HQY for $239,571 on Jul 03 ’25. On Jul 03 ’25, another insider, Stephen Neeleman, who serves as the Officer of the company, bought 1,049 shares for $100.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 8161547776 and an Enterprise Value of 8980407296. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 68.69, and their Forward P/E ratio for the next fiscal year is 21.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.57 while its Price-to-Book (P/B) ratio in mrq is 3.85. Its current Enterprise Value per Revenue stands at 7.225 whereas that against EBITDA is 22.135.
Stock Price History:
The Beta on a monthly basis for HQY is 0.54, which has changed by 0.16547298 over the last 52 weeks, in comparison to a change of 0.16564083 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is -6.99%, while the 200-Day Moving Average is calculated to be -2.88%.
Shares Statistics:
The stock has traded on average 1.04M shares per day over the past 3-months and 868090 shares per day over the last 10 days, according to various share statistics. A total of 86.71M shares are outstanding, with a floating share count of 84.61M. Insiders hold about 2.16% of the company’s shares, while institutions hold 106.90% stake in the company. Shares short for HQY as of 1751241600 were 5284130 with a Short Ratio of 5.10, compared to 1748563200 on 5960094. Therefore, it implies a Short% of Shares Outstanding of 5284130 and a Short% of Float of 7.0700005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
